Forte Biosciences 1 article

The protein-therapeutics profile of Forte Biosciences is anchored in autoimmune therapeutics, with pathogenic T-cell activity control adding the receptor, cytokine or multispecific design context that distinguishes its platform. A further layer of its biologics work includes natural killer cell pathway modulation and celiac disease therapeutics, with autoimmune antibody drug development providing the disease, target or immune-mechanism context. GenoMethods keeps antibody formats, molecular targets and individual biologics separate from the company; the protein-therapeutics profile of Forte Biosciences also includes cytokine receptor blockade.